Nymox Pharmaceutical
NYMX
#10712
Rank
S$23.19 M
Marketcap
Country
S$0.25
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -S$3.04 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -S$8.3 Million, an increase over its 2021 earnings that were of -S$15.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$3.04 Million-63.41%
2022 -S$8.3 Million-47.71%
2021 -S$15.87 Million6.61%
2020 -S$14.88 Million-10.91%
2019 -S$16.71 Million24.24%
2018 -S$13.45 Million-20.03%
2017 -S$16.81 Million2.71%
2016 -S$16.37 Million-63.86%
2015 -S$45.29 Million674.44%
2014 -S$5.85 Million-6.11%
2013 -S$6.23 Million-35.66%
2012 -S$9.69 Million-20.76%
2011 -S$12.22 Million38.33%
2010 -S$8.84 Million35.59%
2009 -S$6.52 Million11.8%
2008 -S$5.83 Million-12.94%
2007 -S$6.7 Million8.85%
2006 -S$6.15 Million36.5%
2005 -S$4.51 Million-4.4%
2004 -S$4.72 Million-14.58%
2003 -S$5.52 Million
2001 -S$4.05 Million-20.54%
2000 -S$5.1 Million21.72%
1999 -S$4.19 Million-25.56%
1998 -S$5.63 Million101.3%
1997 -S$2.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.01 B-1,202,274.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.46 B-490,197.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.34 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.55 B-1,440,405.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.74 B-63,774.22%๐Ÿ‡บ๐Ÿ‡ธ USA